Maravai Lifesciences Holdings (MRVI) Shares Outstanding (2020 - 2026)

Maravai Lifesciences Holdings' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $146.4 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2.09% year-over-year to $146.4 million in Q1 2026; TTM through Mar 2026 was $146.4 million, a 2.09% increase from a year earlier, with the FY2025 full-year figure at $144.4 million, up 4.68% from the prior year.
• Shares Outstanding (Entity) improved to $146.4 million in Q1 2026 per MRVI's latest filing, from $144.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $146.4 million in Q1 2026 and bottomed at $131.5 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $132.3 million (2024), against an average of $136.7 million.
• Across the five-year window, Shares Outstanding (Entity) surged 36.05% in 2022 and increased 0.19% in 2023, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $131.5 million in 2022, then advanced by 0.28% to $131.9 million in 2023, then grew by 4.54% to $137.9 million in 2024, then rose by 4.68% to $144.4 million in 2025, then climbed by 1.43% to $146.4 million in 2026.
• Per Business Quant, the three latest MRVI Shares Outstanding (Entity) figures stand at $146.4 million (Q1 2026), $144.4 million (Q4 2025), and $144.7 million (Q3 2025).